Communiqués Adimmune Corporation

Actions

4142

TW0004142005

Cours en clôture Taiwan S.E. Autres places de cotation 00:00:00 28/06/2024			Varia. 5j.	Varia. 1 janv.
28,55 ^TWD	+0,35%		+0,35%	-13,88%

15/05	Adimmune Corporation annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI
28/03	Adimmune Corporation annonce ses résultats pour l'exercice clos le 31 décembre 2023	CI

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Adimmune : The Company is invited to the online institutional investor conference hosted by Cathay Securities Corporation	16/08/22	PU
Adimmune : announces financail statements of 2022 second quarter.	12/08/22	PU
Adimmune : To announce the completion status of execution of the stock repurchase	09/08/22	PU
Adimmune : Clarification of media reporting	27/07/22	PU
Adimmune : The Company is invited to the institutional investor conference hosted by First Securities Inc.	25/07/22	PU
Adimmune : Announcement of members of the Company's 3rd audit committee	29/06/22	PU
Adimmune : The Company's board of directors re-elected Dr. Chan Chi-Hsien as the chairperson	29/06/22	PU
Adimmune : Important resolutions of the Company's 2022 regular shareholders' meeting	29/06/22	PU
Adimmune : The list of the newly elected 21st directors (including independent directors) of the Company	29/06/22	PU
Adimmune : The Company's shareholders' meeting approved the release of non-compete restrictions on directors	29/06/22	PU
Adimmune : Clarification of media reporting	21/06/22	PU
Adimmune : Announcement of the board resolution to repurchase treasury shares	09/06/22	PU
Adimmune : Resolution by the board of directors not to distribute dividends.	29/03/22	PU
Subject:The Company's Board of Directors resolved to convene the 2022 Annual General Shareholders Meeting	29/03/22	PU
Adimmune : The board of directors approved the company's 2021 consolidated financial report.	29/03/22	PU
Subject:Announcement of the approval of the Company's quadrivalent influenza vaccine from China's National Medical Products Administration	11/02/22	PU
Adimmune : Change to the research and development officer of the company	26/01/22	PU
Taiwanese COVID-19 vaccine still has hurdles to clear: CECC expert	07/05/20	AQ
Adimmune : Taiwan's coronavirus vaccine proven effective on animal subjects	06/05/20	AQ
Adimmune : Taiwanese company looking to start Wuhan virus vaccine trials in May	11/03/20	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Adimmune Corporation

Actions

4142

TW0004142005

Communiqués

Filtres